Evidence map›Paper›PMID 36482598›Full record

ArticleMedicine2022

Radical radiotherapy for cervical cancer and meningioma with a history of Guillain-Barré syndrome: A case report.

Kangli Deng, Yanxin Yu, Liben Ge, Kangyan Deng, Mo Zhang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kangli DengDepartment of Health Management & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Yanxin YuDepartment of Oncology, Chengdu 363 Hospital Affiliated to Southwest Medical University, Chengdu, China.
Liben GeDepartment of radiotherapy, Jilin Provincial People's Hospital, Changchun, China.
Kangyan DengDepartment of Gynecology, Langzhong People's Hospital, Langzhong, China.
Mo ZhangDepartment of Health Management & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.ORCID 0000-0003-3460-4278
University of Electronic Science and Technology of China · CNPeople 's Hospital of Jilin Province · CNSouthwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleGuillain-Barré syndrome (GBS) is a rare autoimmune disease. Patients with cervical malignancies and intracranial meningiomas after the course of GBS are even rarer. There are no relevant reports at present. PATIENT CONCERNS: We report a patient who developed cervical cancer (CC) and intracranial meningioma simultaneously after the course of GBS. DIAGNOSES: The history, pelvic enhanced magnetic resonance imaging (MRI) and pathology confirmed cervical squamous cell carcinoma, and the head enhanced MRI confirmed meningioma.

interventionAfter multi-disciplinary team, the patient received head stereotactic radiosurgery for meningioma and radical radiotherapy for CC. OUTCOMES: The follow up for 1 year after treatment revealed a complete remission of the cervical tumor, stable disease of the meningioma, and no signs of GBS recurrence. Up to now, the general condition of the patient is acceptable and the curative effect is satisfactory. LESSONS: This case report aims to improve the oncologists' understanding of malignant tumors with rare autoimmune diseases and provide treatment reference for similar diseases in the future.

Indexed as

Guillain-Barre SyndromeMeningeal NeoplasmsMeningiomaUterine Cervical NeoplasmsFemaleHumansRemission Induction

Identifiers

PMID36482598
PMCPMC9726365
OpenAlexW4310874141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.